Benzinga | Jan 13, 2022 11:47AM EST

Prellis Biologics Announces Collaboration And License Agreement With Bristol Myers Squibb; Prellis To Receive Undisclosed Upfront Payment, Funding For Research And Milestones

https://www.businesswire.com/news/home/20220113005314/en/